We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,402
Reduced
945
Closed
112
Avg Time Held
25.8
quarters
Top 10 Avg Time Held
18.2
quarters
Top 20 Avg Time Held
19.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NEXI
4376
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $115K | ﹤0.01% |
18,959
| – | – |
2021 Q1
7 quarters
|
|
|
MTCR
4377
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $114K | ﹤0.01% |
254,492
| – | – |
2020 Q3
9 quarters
|
|
|
VRPX
4378
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $111K | ﹤0.01% |
711
-773
| -52% | -$176K |
2021 Q3
5 quarters
|
|
4379
Similarweb
SMWB
$799M
| $110K | ﹤0.01% |
17,096
| – | – |
2022 Q2
2 quarters
|
|
4380
Riskified
RSKD
$1.13B
| $110K | ﹤0.01% |
+23,713
| New | +$110K |
2022 Q4
0 quarters
|
|
|
NXXT
4381
NextNRG Inc
NXXT
$10.9M
| $109K | ﹤0.01% |
1,943
| – | – |
2021 Q4
4 quarters
|
|
4382
NeuroOne Medical Technologies
NMTC
$10.2M
| $108K | ﹤0.01% |
14,944
+1,124
| +8% | +$10.1K |
2021 Q4
4 quarters
|
|
|
LGMK
4383
DELISTED
LogicMark
LGMK
| $107K | ﹤0.01% |
481
-70
| -13% | -$24.8K |
2015 Q1
31 quarters
|
|
|
GET
4384
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
| $107K | ﹤0.01% |
62,825
-44,616
| -42% | -$79.5K |
2021 Q4
4 quarters
|
|
|
ASPU
4385
DELISTED
ASPEN GROUP, INC.
ASPU
| $105K | ﹤0.01% |
339,841
-605,821
| -64% | -$220K |
2017 Q3
21 quarters
|
|
|
SGTX
4386
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $105K | ﹤0.01% |
23,147
| – | – |
2020 Q4
8 quarters
|
|
|
FGC
4387
FG Communities Holdings Inc. Common Stock
FGC
$31.6M
| $103K | ﹤0.01% |
290
| – | – |
2014 Q2
34 quarters
|
|
|
ADIL
4388
Adial Pharmaceuticals
ADIL
$11.4M
| $103K | ﹤0.01% |
766
-221
| -22% | -$38.7K |
2018 Q4
16 quarters
|
|
4389
Pasithea Therapeutics
KTTA
$15.6M
| $103K | ﹤0.01% |
8,010
+18
| +0.2% | +$360 |
2021 Q4
4 quarters
|
|
|
NEWP
4390
New Pacific Metals
NEWP
$1.22B
| $103K | ﹤0.01% |
45,642
| – | – |
2021 Q2
6 quarters
|
|
4391
Soluna Holdings
SLNH
$220M
| $103K | ﹤0.01% |
15,737
| – | – |
2021 Q2
6 quarters
|
|
4392
Aprea Therapeutics
APRE
$7.61M
| $103K | ﹤0.01% |
15,501
+21
| +0.1% | +$222 |
2019 Q4
12 quarters
|
|
|
VYNT
4393
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $102K | ﹤0.01% |
145,719
-5,641
| -4% | -$9.18K |
2013 Q4
36 quarters
|
|
|
HURA
4394
TuHURA Biosciences
HURA
$125M
| $102K | ﹤0.01% |
424
+1
| +0.2% | +$222 |
2020 Q3
9 quarters
|
|
|
SLNO
4395
DELISTED
Soleno Therapeutics
SLNO
| $98.9K | ﹤0.01% |
49,939
-71,147
| -59% | -$88.5K |
2015 Q1
31 quarters
|
|
|
KLR
4396
DELISTED
Kaleyra, Inc.
KLR
| $97.8K | ﹤0.01% |
37,007
+5,673
| +18% | +$18.9K |
2022 Q2
2 quarters
|
|
|
AUVI
4397
DELISTED
Applied UV, Inc. Common Stock
AUVI
| $96.6K | ﹤0.01% |
854
| – | – |
2021 Q1
7 quarters
|
|
4398
LiqTech
LIQT
$13.4M
| $95.9K | ﹤0.01% |
31,550
+43
| +0.1% | +$138 |
2014 Q1
35 quarters
|
|
|
SOPA
4399
DELISTED
Society Pass
SOPA
| $95.3K | ﹤0.01% |
6,415
+1,660
| +35% | +$36.4K |
2021 Q4
4 quarters
|
|
|
PTIX
4400
DELISTED
Performance Technologies
PTIX
| $94.5K | ﹤0.01% |
4,220
-295
| -7% | -$8.89K |
2021 Q2
6 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.